HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JNM Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rettenbacher, L. Articles by Galvan, G. Search for Related Content PubMed PubMed Citation Articles by Rettenbacher, L. Articles by Galvan, G.

Reproducibility of Lymphoscintigraphy in Cutaneous Melanoma: Can We Accurately Detect the Sentinel Lymph Node by Expanding the Tracer Injection Distance from the Tumor Site?

Department of Nuclear Medicine and Endocrinology and Department of Dermatology, Salzburg State Hospital, Salzburg; and Department of Radiology and Nuclear Medicine, Hospital Barmherzige Brüder, Salzburg, Austria

The aim of the study was to determine whether the sentinel lymph node (SLN) can be accurately detected in cutaneous melanoma patients when the injection distance from the tumor site is expanded. Methods: In 100 patients with cutaneous melanoma, lymphoscintigraphy was performed twice. First, we injected 37 MBq ^99mTc nanocolloid intracutaneously at a 2- to 5-mm distance from either the melanoma or the biopsy scar. The injection was followed by dynamic imaging, which continued until the SLN became visible. On another day, we repeated the investigation, injecting the radiopharmaceutical intracutaneously exactly 10 mm from the previous injection site. The detected SLNs of both investigations were compared to determine the number and location of SLNs for each patient. Results: The SLN identification rate was 94% with close injection and 100% with 10-mm-distant injection. All SLNs detected with close injection were visible with distant injection. In 84 of 100 patients, the images of both investigations showed the same number and location of SLNs. In the remaining 16 patients, an additional SLN was detected with the distant injection. Conclusion: The reproducibility of lymphoscintigraphy using different injection distances was 84%. The discordance in the remaining 16% was caused by detection of a lymph node in addition to the original SLN with distant injection. Diagnostic excision of the primary tumor before lymphoscintigraphy was possible without preventing detection of the original SLN. However, in 16% of our patients, excision of an additional lymph node had to be considered when lymphoscintigraphy was performed after diagnostic excision.

Key Words: lymphoscintigraphy • cutaneous melanoma • excisional biopsy

Related articles in JNM:

Reproducibility of Cutaneous Lymphoscintigraphy: Same or Different Lymphatic Routes and Sentinel Nodes After Reinjection?

Renato A. Valdés Olmos and Omgo E. Nieweg
JNM 2001 42: 430-431. [Full Text]  

This article has been cited by other articles:

				M. Matter, M. Nicod Lalonde, M. Allaoua, A. Boubaker, D. Lienard, O. Gugerli, J.-P. Cerottini, H. Bouzourene, A. Bischof Delaloye, and F. Lejeune The Role of Interval Nodes in Sentinel Lymph Node Mapping and Dissection for Melanoma Patients J. Nucl. Med., October 1, 2007; 48(10): 1607 - 1613. [Abstract] [Full Text] [PDF]

				P. J. Tanis, R. A. Valdes Olmos, S. H. Muller, and O. E. Nieweg Lymphatic Mapping in Patients with Breast Carcinoma: Reproducibility of Lymphoscintigraphic Results Radiology, August 1, 2003; 228(2): 546 - 551. [Abstract] [Full Text] [PDF]

				R. A. Valdés Olmos and O. E. Nieweg Reproducibility of Cutaneous Lymphoscintigraphy: Same or Different Lymphatic Routes and Sentinel Nodes After Reinjection? J. Nucl. Med., March 1, 2001; 42(3): 430 - 431. [Full Text]